Melville Engle is the founder of Predictive Oncology. Predictive Oncology has raised $55M in total funding. Based in Eagan, United States.
Melville Engle was the CEO and Chairman of Predictive Oncology, a company that utilizes AI and a biobank of over 150,000 cancer tumors to develop optimal cancer therapies and aid in drug discovery. He joined the company's Board of Directors in 2016, became Chairman in January 2020, and was appointed CEO in March 2021. Engle played a significant role in expanding the company's offerings and led the acquisition of zPREDICTA.
Full founder directory · Investor directory · Company funding database · Fundraising library